Halve eeuw Europese farmaceutische wetgeving

Patients require quick access to safe, affordable, effective and good quality medicines. We now celebrate fifty years of European pharmaceutical legislation aimed at therapeutic innovation.
This legislation provides adequate protection of clinical trial subjects, efficient control of products before and during marketing and dissemination of objective information for a more rational use. It also provides incentives for the development of orphan drugs for rare diseases and of specific medicines for children. On 28 September 2015 the European Commission organised the conference ‘50 Years of EU Pharma: achievements and future perspectives' (Health-EU newsletter, 25 september 2015).
Klik hier voor het focus artikel van de Health-EU nieuwsbrief.
Klik hier voor meer informatie over de conferentie '50 Years of EU Pharma legislation, inclusief video-opname.
Klik hier voor meer informatie over de NVC E-Course Pharmaceutical Packaging.

Heeft u vragen over dit onderwerp, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411. Dit bericht is ook opgenomen in ons maandelijkse overzicht, de NVC Members-only Update.